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Coarctation of the Aorta in the Adult
DEFINITION / MORPHOLOGY /PATHOPHYSIOLOGY
Coarctation of the Aorta (CoA) is, as part of a generalized arteriopathy, 
a complex cardiovascular disorder, and not only a circumscript narrowing 
of the aorta in the area where the ductus arteriosus inserts.(1, 2)
In 1760 Morgagni described CoA, seen during the autopsy of a monk, 
and refers to a similar case reported by the elder Meckel in 1750.(3) 
More detailed patho-anatomical descriptions followed from Jordan 
(1827), Reynaud (1828) and others.(4)
In 1903 LM Bonnet ordered this lesion into infantile and adult types. 
The categorization was later revised to preductal and postductal 
forms.
The infantile type was characterized by a long, narrowed aortic segment, 
located proximal to the ductus, persistence of the ductus and death in 
early infancy, often due to congestive cardiac failure. The adult type was 
distinguished by a more circumscript, postductal narrowing of the aorta, 
accompanied by a closed ductus and clinical manifestation in later life. 
This classifi cation has been widely replaced and currently, in view of the 
pathogenesis, all types of CoA are esteemed to be “juxtaductal”.
In adults CoA is almost always located just below the origin of the left 
subclavian artery at the conjunction of the distal aortic arch to the 
descending aorta. In rare cases CoA may be localized ectopically, 
anywhere in the ascending, descending or abdominal aorta.
The pathogenesis of CoA is still not completely understood; the “ductus 
tissue theory” and the “hemodynamic theory” have recently been 
proposed. 
In the ductus tissue theory, postnatal constriction of aberrant ductal 
tissue and/or intrauterine alterations of blood fl ow through the aortic 
arch are incriminated as cause. Others have proposed that CoA 
develops from hemodynamic alteration that reduces the volume of 
blood fl ow through the fetal aortic arch and isthmus. 
CoA is often seen in association with a bicuspid aortic valve, a 
subvalvular, valvular, or supravalvular aortic stenosis, hypoplastic left 
heart syndrome, mitral valve stenosis or complex congenital heart 
defects with one of those entities.
CoA may occur as either a localized stenosis or as a long and hypoplastic 
aortic segment. In the localized form, there is a shelf-like infolding of the 
posterior aortic wall into the aortic lumen, either opposite, proximal or 
distal to the ductus arteriosus. 
The shelf consists of thickened aortic media and intima and is always in 
continuity with the muscular tissue of the ductus arteriosus. At times of 
ductal closure anomalous fi broductal tissue around the aorta tracks the 
shelf towards the ductal orifi ce, causing luminal obstruction.
Diffuse forms of CoA are characterized by a tubular hypoplasia involving 
the aortic arch or the aorta distal to the origin of the left subclavian 
artery and the ductus area.
CoA may occur as an isolated defect or combined with other important 
intracardiac and/or extracardiac lesions. Simple CoA refers to CoA in 
the absence of other relevant lesions. However, even simple CoA is 
often accompanied by anomalies, previously thought to be insignifi cant, 
like bicuspid aortic valve (up to 85%), mitral valve anomalies, and/or 
intracranial aneurysms. Complex CoA refers to the association with 
other important lesions, e.g. ventricular septal defects and major mitral 
or aortic valve abnormalities. Sometimes, CoA complicates complex 
heart defects, such as transposition of the great arteries, Taussig-Bing 
anomaly, double-inlet left ventricle, tricuspid atresia with transposition 
of the great arteries, and hypoplastic left heart syndrome. The association 
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 Coarctation of the aorta is a complex 
systemic cardiovascular disease. The most prominent feature 
is the stenosis at the aortic isthmus that can be removed 
surgically or by catheter intervention. However, there are 
often concomitant cardiovascular problems like a bicuspid 
aortic valve, vascular wall abnormalities, arterial hyper-
tension and vascular aneurysms. Therefore, regular life-long 
medical follow-up is necessary including modern imaging 
techniques, even after successful primary treatment.
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of multiple left-sided obstructive lesions with coarctation is referred to 
as the Shone-complex. On the other hand, CoA is rarely associated 
with severe right ventricular outfl ow tract obstructions. CoA can also 
be associated with Turner’s or William’s syndrome, congenital rubella or 
neurofi bromatosis, Takayasu aortitis or trauma.
The foremost clinical feature of CoA is arterial hypertension in the 
upper body and arms (prestenotic) and low blood pressure in the 
lower body and legs. This imposes signifi cant afterload on the left 
ventricle, resulting in increased wall stress and compensatory left 
ventricular hypertrophy. Left ventricular systolic and diastolic dysfunction 
may develop secondary to elevated afterload and related to reduced 
ventricular compliance caused by left ventricular hypertrophy, increased 
interstitial fi brosis or myocardial mass.
An increasing afterload of the left ventricle induces the development of 
arterial collaterals, which bypass the CoA.
Arterial hypertension may develop due to the mechanical obstruction 
and/or may – at least in part – be caused by a diminished (post-stenotic) 
renal blood fl ow and a subsequent activation of the renin-angiotensin-
aldosterone system. An additive activation of the central sympathetic 
nervous system may also be responsible for hypertension.
In CoA patients early elastic fi ber fragmentation, fi brosis and so-called 
“cystic medial necrosis” could be uncovered in the wall of the ascending 
and descending aorta.(2, 5) These wall abnormalities result in an increased 
stiffness of the aorta(6, 7) and of the carotid arteries,(8) in a blunted 
baroreceptor refl ex,(9) in an increased brachial pulse wave velocity(10) 
and may be related to late aneurysm formation or aortic dissection.
Aortic stiffness and increased pulse wave velocity are also present late 
after CoA repair.(8, 10) Furthermore, an increased carotid intima-media 
thickness was found in young adults(11, 12) and children(13) with CoA, as 
well as a diminished endothelium dependent and independent 
vasodilatation in the right brachial artery.(10, 13-15)
EPIDEMIOLOGY AND GENETICS                                    
CoA is a relatively common type of congenital heart defect that 
accounts for 5-8% of all congenital heart defects. 
The prevalence of isolated CoA is about 0.33 per 1000 live births.(16) 
Series from Southeast Asian countries show lower incidence.(17) In 
Japan, the reported incidence varied between 0.3-1.5%. Ongley 
mentioned non-existence of CoA in Thailand.(18)
Besides sporadic cases, genetic infl uences are possible. CoA is more 
common in people with Turner’s syndrome. Sporadically it is associated 
with William Beuren syndrome or Noonan syndrome. Furthermore, 
there are family clusters with a high prevalence of different left heart 
obstructive defects including CoA, bicuspid aortic valve, congenital 
valvular aortic stenosis, and hypoplastic left heart syndrome,(19, 20) 
suggesting an oligogenetic pattern of inheritance in those families.
Typical CoA is more common in white males than females, with a male-
to-female ratio of 1.3 – 2.0: 1.
CLINICAL PRESENTATION                                                 
Depending on the degree of stenosis and associated cardiovascular 
defects, signifi cant, unrepaired CoA commonly causes problems already 
in early infancy. 
According to historic series, 60% of untreated patients with symptomatic, 
high-grade CoA and 90% of patients with complicated CoA died within 
the fi rst year of life. Of those who survived the fi rst two years, 25% 
died before age 20, 50% before age 32, 75% before age 46, and 92% 
before age 60.(21) A few reports exist of patients living to 78, 85, or 
indeed 92 years of age.(22)
Untreated patients surviving into adulthood typically have milder forms 
of CoA and may remain asymptomatic and therefore undetected until 
adolescence or even adulthood.
Major problems in the natural course, possibly causing death, include 
left ventricular failure (28%), intracranial hemorrhage (12%), bacterial 
endocarditis (18%), aortic rupture/dissection (21%), premature 
coronary artery disease, and associated heart defects.(23)
Medical history and physical fi ndings in Coarctation
Signs and symptoms of CoA depend on the severity of the disorder. 
Serious CoA is likely to exhibit signs and symptoms early in life, while 
mild cases may not become evident until adulthood.
Adults have a tendency to have milder CoA with signifi cant collaterals 
and therefore often have no or mild symptoms. Adult patients often 
present with arterial hypertension or a murmur. 
Key symptoms are headache, nosebleeds, dizziness, tinnitus, shortness 
of breath – especially during exercise – abdominal angina, leg cramps, 
exertional leg fatigue, cold feet, and even intracranial hemorrhage 
attributed to upper body arterial hypertension.
Cardinal clinical features include upper body hypertension, lower body 
hypotension, diminished, delayed femoral pulses, a blood pressure 
decrease between upper and lower extremities, and palpable collateral 
arteries running over the medial aspects of the scapulae, the lateral 
chest wall, and between the ribs. 
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Clinical diagnosis is based on simultaneous palpation of brachial and 
femoral pulses and blood pressure measurement on all extremities. 
Usually the systolic blood pressure in the lower extremities should be 
5 - 10 mmHg higher compared with the upper extremities.(24) A blood 
pressure difference of more than 20 mm Hg in favor of the arms may 
be indicative of CoA. 
A diminished left brachial pulse suggests an anomalous origin of the 
left subclavian artery below the coarctation site or a stenosis, a weak 
right brachial pulse an aberrant, distally displaced origin of the right 
subclavian artery. 
Other physical fi ndings include a thrill in the suprasternal notch or the 
neck vessels, and a heaving but not displaced apex beat. 
On auscultation the aortic closure sound is loud. Patients with a bicuspid 
aortic valve or an aortic aneurysm have an early systolic ejection click. 
An additional systolic ejection murmur transmitted to the carotids may 
be found in the 2nd parasternal intercostal space in CoA patients with 
a bicuspid aortic valve or arterial hypertension. 
Between the scapulae, a vascular murmur may be heard that is separated 
from the fi rst heart sound and lasts beyond the second heart sound. 
Collateral vessels may additionally be audible as continuous murmurs. 
Electrocardiography may show varying degrees of left atrial and left 
ventricular (LV) pressure load and signs of LV ischemia or strain.
The chest X-ray may show an ectatic ascending aorta, kinking or double 
contouring in the region of the descending aorta (“fi gure-3”-sign), and 
widening of the soft-tissue shadow of the left subclavian artery. 
Rib notching at the postero-inferior borders of the 3rd and 4th (to 8th) 
ribs, secondary to intercostal collaterals, is often seen in adults. 
Transthoracic echocardiography may provide important information 
regarding site, structure, and extent of the stenosis as well as systolic 
and diastolic left ventricular function and hypertrophy, associated 
cardiac abnormalities, aortic diameters, and supraaortic vessels. 
Unfortunately the aortic isthmus itself is often not readily detectable in 
adults, as the proximity of the left bronchus frequently causes artifact 
superimposition. Doppler studies may show a turbulent fl ow pattern 
with a diastolic “run-off ”-phenomenon and increased systolic fl ow 
rates distal to the coarctation. 
The Bernoulli equation, estimating the gradient from the peak systolic 
blood fl ow velocity, is only validated for valve stenosis and may 
overestimate CoA, especially in a stiff tubular structure with an 
enhanced pulse wave velocity. In CoA the fl ow rates proximal to and 
within the stenosis have to be taken into account to avoid an 
overestimation of the pressure gradient. If the proximal fl ow rate is 
>1.0 m/sec, the expanded Bernoulli equation (Δp = 4 (V2
2 -V1
2)) will 
have to be used.(25)
Comparison of catheter derived gradients with gradients derived by 
Doppler echocardiographic maximum and mean velocity is problematic. 
However, a resting peak systolic velocity of ≥ 3,2 m/s and a diastolic 
velocity of ≥ 1,0 m/s may be suggestive of signifi cant coarctation.
In the presence of an extensive bypassing collateral network, the systolic 
and diastolic gradients are not very reliable. Also, after surgical 
coarctation repair a gradient may develop even in the absence of 
signifi cant narrowing due to a lack of aortic compliance. 
Recent Doppler studies indicate that differentiation between restenosis 
and enhanced aortic stiffness can be performed by analyzing diastolic 
fl ow patterns at the isthmus (Figure 1). A pan-diastolic run-off is the 
most important echocardiography sign of restenosis.(26)
The role of transesophageal echocardiography is a minor one in adults 
because the quality of aortic isthmus imaging tends to be poor.
Intravascular ultrasound may give additional information regarding re-
stenosis, local aneurysm formation or intramural hematoma. However, 
non-invasive imaging techniques with similar resolution are available 
and, therefore, preferred today.
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 FIGURE 1: Continuous wave Doppler ﬂ ow velocity at the aortic coarctation site 
indicating a restenosis: The peak velocity (A) can not differentiate between restenosis 
and enhanced aortic stiffness. However, the pan-diastolic run-off (B) is the more speciﬁ c 
echocardiography sign of restenosis (with courtesy to J. Schoetzau).
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Magnetic resonance imaging (MRI) and computed tomography (CT) 
are the favorite noninvasive techniques to evaluate CoA or re-CoA in 
adults. Both methods depict site, extent and degree of the aortic 
narrowing, the aortic arch, the pre- and post-stenotic aorta, and the 
collateral vessels, if present. Moreover, modern MRI methods even 
provide an estimation of blood fl ow and pressure gradients across the 
stenosis, and provide information on the collateral fl ow.(27)
Likewise, it is of utmost importance to reliably detect complications 
related to the natural history or to therapeutic procedures, e.g. aneurysm 
of the ascending aorta or at the site of previous surgery or intervention, 
aortic dissections, re- or residual stenosis or a hypoplastic aortic arch. 
The course and patency of prosthetic bypasses can also be detected.
Cardiac catheterization may not be required. Manometry and 
angiocardiography delineate the anatomy of the entire aorta and the 
supraaortic vessels, the degree of hypoplasia of the transverse aortic 
arch, the extent of collaterals, determine the pressure gradient across 
the coarctation, detect associated heart defects and evaluate left 
ventricular function and coronary status, particularly when other 
imaging modalities fi ndings are not indicative. 
At catheterization a signifi cant CoA with a peak-to-peak gradient of > 
20 mm Hg across the CoA is indicative of signifi cant obstruction in the 
absence of a well-developed collateral circulation. However, the gradient 
depends on not only the extent of aortic narrowing but also the size 
and number of collateral vessels and cardiac output. If there is extensive 
collateral circulation, there may be minimal or no pressure gradients, 
even in high-grade CoA. 
Due to the increased risk of premature coronary artery disease, 
coronary angiography is important in patients with coronary risk factors 
and in patients older than 40 years.
Interventional and surgical treatment
Treatment options for CoA depend on age at time of diagnosis, the 
degree of stenosis, and the type of associated cardiac defects. 
Balloon angioplasty for aortic CoA has been available since 1982. This 
procedure enlarges the size of the narrowed segment, lowers the 
pressure gradient and diminishes collateral vessels.
Even if CoA can primarily be released by balloon angioplasty, the aortic 
diameter may decline due to the elastic recoil of the aortic wall. 
Such recoil can be avoided with implantation of endovascular stents 
(Figure 2), which have been available for CoA since 1991.(28) Main 
indications for balloon-expandable or self-expandable stents are 
currently long-segment coarctation, associated hypoplasia of the isthmus 
or aortic arch, tortuous CoA with malalignment of the proximal and 
distal aortic segment, and recurrent aortic CoA or an aneurysm 
following prior surgical or balloon therapy.(29, 30)
Experience with covered stents in highly selected patients with a 
postangioplasty aneurysm, tortuous aortic arch and isthmus, associated 
patent ductus arteriosus, and extremely narrow CoA is limited.(30) 
Biodegradable stents are under development. 
In conclusion, in experienced centers angioplasty with or without stent 
implantation has become an effective and safe treatment option for 
children and adults with re- or residual CoA after prior surgery, although 
long-term follow-up studies are lacking.(31, 32) Although most frequently 
used in neonates, infants and children, it can also be used in adults.(33) In 
principle, this procedure may also be indicated in uncomplicated native 
aortic coarctation, but the point is controversial.
Surgical relief of the stenosis was introduced more than 60 years 
ago.(34-36) Since 1944 a lot of different operative techniques for the 
surgical removal of CoA have been designed.(37) The most important 
ones are resection and end-to-end anastomosis, resection and extended 
end-to-end anastomosis, prosthetic patch aortoplasty, subclavian fl ap 
aortoplasty, interposition of a (tube) graft, bypass tube (jump) grafts, 
etc. They all have specifi c advantages, disadvantages and long-term 
problems. 
The selection of procedure depends on the nature, site and extent of 
the coarctation, and on the patient’s age. 
CoA repair in adolescents or adults is usually undertaken electively. 
There is a tendency to operate as early as possible after diagnosis to 
minimize late mortality and morbidity. However, the age-related risks 
and rate of complications have to be taken into account.
 FIGURE 2: Stent implantation in a 16-year-old patient with restenosis after coarctation 
repair with end-to-end anastomosis at the age of 11 months. Stent implantation 
reduced the invasively measured systolic gradient from 25 mmHg to -1 mmHg.
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to be 2 – 5 years. In this age group the aortic diameter is usually larger 
than half the anticipated adult size, reducing the risk of relevant 
residual stenosis after operation. However, at the same time sequelae 
from hypertension, progressive left ventricular hypertrophy and/or -
dysfunction may increase. Beyond age six arterial hypertension often 
persists.
Older children and adults are operated on soon after diagnosis. The 
operative mortality is high in neonates and infants, and low in older 
children. Beyond age 30 or 40, intraoperative mortality increases as a 
consequence of degenerative aortic wall changes, coexisting bicuspid 
aortic valve disease, mitral valve abnormalities, coronary artery disease, 
and end-organ damage from systemic arterial hypertension.
A survey of 11 major studies which include 2355 patients operated on 
between 1946 and 1994, showed an acute mortality between 3% and 
32%, which was strongly correlated with the complexity of associated 
lesions.(38) Today, the surgical risk in simple CoA is less than 1%. 
All in all, there is an ongoing discussion about the optimal treatment 
strategy. Few randomized studies with short- and mid-term follow-up 
showed the advantages of surgical techniques over balloon dilatation in 
primary treatment.(39) However, comparative data regarding stent 
implantation are still missing.
MEDICAL INTERVENTION                                               
Patients without a signifi cant residual systolic gradient, with normal 
blood pressure at rest and exercise, can do without restrictions on 
physical activity. 
As longstanding arterial hypertension increases the risk of coronary 
artery disease, cholesterol levels should be controlled and regulated, 
obesity and smoking be avoided.
Medical treatment is usually used to control blood pressure before 
and after surgery. Long-term postoperative hypertension can be 
treated primarily with betablockers, vasodilators (ACE inhibitors, AT-II 
antagonists) or diuretics. However, it has to be kept in mind that ACE-
inhibitors or AT-II antagonists may have adverse effects in CoA if residual 
arch obstruction or re-CoA exists. To get these patients “normotensive” 
may cause an inadequate lower-body perfusion and may produce renal 
failure. Medical drug treatment often fails to achieve normotension, if a 
signifi cant restenosis is present.
In the early postoperative and post-interventional course of CoA 
treatment sometimes a post-coarctation syndrome can be seen. This 
paradoxical hypertension is caused by a delay in the reset of the 
baroreceptor refl ex mainly in the fi rst 2-14 days after coarctation repair. 
Clinically, it consists of a severe arterial hypertension that can progress 
to a disastrous mesenteric arteritis. Early and aggressive antihypertensive 
treatment is necessary. Periprocedural prophylaxis with betablockers 
has shown to be effective.(40, 41) 
LATE OUTCOME                                                                   
Survival and functional status
Surgery improves, at least in the short term, clinical symptoms, blood 
pressure and also survival while, because of cardiovascular complications 
and arterial hypertension, long-term mortality is still higher than in the 
general population.(42, 43)
In a Mayo Clinic follow-up study, including 646 patients with a simple 
CoA, operated on between 1946 and 1981, the postoperative 10-year 
survival was 91%, 20-year survival was 84%, and 30-year survival 72%.(44) 
In this series, 87 cases of late death occurred in the long-term follow-up 
among 571 patients. The mean age at death was 38 years, commonly 
attributed to coronary artery disease, sudden cardiac death, left 
ventricular failure, cerebrovascular accidents and ruptured aortic 
aneurysm.(44)
Exercise capacity is slightly compromised, but far less than in other 
congenital heart defects.(45)
Residua, sequelae and complications in the long term
The most eminent residua, sequelae and complications are arterial 
hypertension, re- or residual coarctation, and aneurysms of the 
ascending aorta or at the site of intervention. 
Additional problems may arise from a bicuspid aortic valve, anomalies 
of the mitral valve, coronary artery disease, infective endocarditis or 
cerebral vascular anomalies.
Arterial hypertension
Arterial hypertension, either at rest or during exercise, is common, 
even after successful treatment of aortic CoA, despite the absence of 
any residual coarctation.(24, 46, 47) In a recent study, even 30% of those 
patients without restenosis and without prosthetic material are 
hypertensive.(48) This is an important risk factor for increased mortality. 
Particularly patients who underwent CoA repair a long time ago or at 
an older age, are threatened for an abnormal blood pressure response.(49) 
The older the patient at the time of CoA repair, the higher the 
postoperative incidence of arterial hypertension.(44) Patients operated 
on between the ages of 2 and 9, more frequently have a normal blood 
pressure later in life . Several studies after CoA repair also suggest a 
rising prevalence of arterial hypertension with increasing length of 
follow-up: 13% at 8 years, 49% at 17 years, and 68% at 30 years.(38)
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In coarctation patients, hypertension is probably correlated to residual 
or recurrent coarctation, structural changes in the arterial wall of 
peripheral and central vessels, alteration of arterial compliance, a 
hypoplastic aortic arch, abnormal vascular vasoreactivity, abnormal 
baroreceptor sensitivity, alterations in the renin-angiotensin-system, 
elevated plasma-epinephrine and -norepinephrine levels, or coexistence 
of essential arterial hypertension.
Hypertensive patients are at risk for premature coronary artery disease, 
ventricular dysfunction, and rupture of aortic or cerebral aneurysms, 
particularly if they reach their 3rd or 4th decade of life. 
The impact of isolated, exercise-induced hypertension, not rarely seen 
in these patients, is still a matter of debate.(49-51)
Re- or residual coarctation
Re- or residual stenosis at the site of coarctation, defi ned as a peak-to-
peak systole pressure gradient in excess of 20 mm Hg with or without 
angiographically demonstrable narrowing,(30) is an important cause of 
morbidity after CoA treatment, as it may induce or aggravate systemic 
arterial hypertension, left ventricular wall mass, coronary artery disease 
and/or congestive heart failure.
Recoarctation or residual stenosis may occur with all known surgical 
techniques and amounts to 3% to 41%.(38, 52) No single technique 
appears to be superior to the others, but is particularly associated with 
smaller patient size, younger age at operation, and the presence of 
associated transverse aortic arch hypoplasia. Moreover, era of operation, 
surgical technique and duration of follow-up further infl uence the risk. 
Children operated on in infancy are at particular risk. In this group the 
incidence of residual and re-stenosis is at 20-38%, in patients older than 
3 years only about 1.5%. 
Re-CoA is also an essential concern after angioplasty. In native adult 
CoA 8-11% of patients develop restenosis. For re-CoA after preceding 
surgical repair, several large angioplasty series demonstrate an early 
success rate (pressure gradient < 20 mm Hg) between 65% and 
100%.(38) Yetman et al. could demonstrate that 72% of patients with 
optimal immediate results did not require reintervention within the 
following 12 years.(53)
Angioplasty of CoA may be ineffective because of elastic recoil, long 
segment narrowing, or multiple serial obstructions. Under such 
circumstances balloon-expandable stents are effective and safe, at least 
in the short and medium term. If necessary, re-expansion of the stent 
to treat re-/residual CoA is effi cient. 
Aneurysms of the ascending aorta or in the region of the 
aortic isthmus
Aneurysms of the ascending aorta or in the region of the aortic isthmus 
have the risk of life-threatening rupture. In several postoperative follow-
up studies cases of late deaths are included, which were related to 
aortic dissection, particularly in the ascending aorta. 
The reasons for aneurysm formation in the ascending aorta (Figure 3) 
are not yet fully understood, but bicuspid aortic valves, independent 
aortic wall changes, and/or arterial hypertension may be responsible.(2)
All types of surgery carry the risk of aneurysm formation. The risk 
depends on the era of the operation, the patient’s age at the time of 
surgery, the postoperative interval and on the surgical technique 
employed.
Recent studies show aortic aneurysms in only 5-9% of patients,(54) while 
older studies after Dacron-patch aortoplasty reported aneurysm 
formation in up to 33% or even 51%. The lowest incidence is described 
after end-to-end anastomosis or after extraanatomic tube grafts. 
 FIGURE 3: Magnetic resonance image with contrast media in volume rendering 
technique depicting an aneurysm of the aortic valve sinus with a diameter of 83 mm in 
a 49-year-old patient 39 years after coarctation repair with end-to-end anastomosis. 
Echocardiography revealed a bicuspid aortic valve with moderate aortic regurgitation. 
The patient underwent Bentall’s operation implanting a mechanical aortic valve and an 
ascending aortic tube graft (with courtesy to S. Fratz).
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Whether and when postoperative aneurysms appear cannot be 
predicted. Many aneurysms are detected as an incidental fi nding, 
because their development rarely produces symptoms. Some aneurysms 
have been found > 30 years after surgery. 
Aneurysms may also occur immediately or several months after balloon 
angioplasty of either native or operated CoA and may be caused by the 
injury to the endovascular layers during treatment and related to medial 
changes in the pre- and post-CoA segments.(30) On the other hand, 
even major iatrogenic tears may decrease and disappear without 
aneurysm formation.
The reported frequency of aneurysms varies from 4-12% after 
angioplasty in native adult CoA and is described in 5% of patients after 
previous surgical repair.(38) The lower incidence in patients after a 
previous surgical repair may be related to surgical scar tissue, which 
may protect against aneurysm and aortic dissection or rupture. 
Infective endocarditis or endarteritis 
Patients with native aortic CoA are predisposed to infective endocarditis 
or endarteritis due to an altered arterial wall structure, associated 
aortic and mitral valve anomalies with an abnormal blood fl ow and 
pressure, or persistent obstruction at the CoA site. Patients remain at 
risk, even after surgical or interventional treatment.
Bicuspid aortic valve
Up to 50% (-85%) of patients with aortic CoA have a bicuspid aortic 
valve.(55) Fibrosis, calcifi cation, or myxomatous degeneration may lead 
to aortic valve stenosis and to aortic valve regurgitation, dilatation of 
the ascending aorta, which may progress to aortic aneurysms and even 
to aortic dissection and rupture.(56) The complication rate of bicuspid 
aortic valves increases with age.
Aneurysms of the Circle of Willis
Berry aneurysms of the circle of Willis or other vessels occur in up to 
10% of patients with CoA.(57) Aneurysm size and risk of rupture tend 
to increase with age and uncontrolled hypertension. 
Many affected patients are asymptomatic until rupture occurs, although 
some aneurysms may leak prior to rupture and generate warning 
symptoms like headache, photophobia, weakness, or others. 
As rupture of a cerebral aneurysm is associated with high mortality, 
specifi c treatment should be considered soon after diagnosis. Screening 
for cerebrovascular aneurysms should be promoted.
Coronary artery disease
As a result of the increased blood pressure the coronary arteries in 
CoA patients may develop premature narrowing or atherosclerosis, 
leading to coronary artery disease in early or mid-adulthood. Even in 
children after coarctation repair an increased intima media thickness as 
early sign of atherosclerosis could be detected.(13) In the Mayo Clinic 
study of 1989, coronary artery disease was the most common cause of 
late postoperative death.(44)
Thoracic musculoskeletal sequelae
Elevation of the left shoulder, deviation of the scapula and/or scapula 
alata can often be recognized in adults after left posterolateral 
thoracotomy for aortic coarctation(58, 59) causing non-cardiac chest pain, 
presumably related to functional impairment of peripheral nerves 
supplying skeletal muscles (latissimus dorsi and serratus anterior 
muscles).(59) 
Precautions in Pregnancy
Fortunately, after successful treatment of CoA many women tolerate 
pregnancy without major problems. Nevertheless, women with 
either native or treated aortic CoA have an increased risk during 
pregnancy due to the physiological hemodynamic and hormonal 
changes, particularly in the third trimester and in the peripartum 
period.(60) Therefore, they need multidisciplinary monitoring throughout 
pregnancy. 
At highest risk are women with unrepaired CoA, arterial hypertension, 
residual CoA. At particular risk of aortic rupture during pregnancy and 
delivery are women with aortic aneurysms due to coarctation. Maternal 
mortality due to aortic dissection(61) and rupture of a cerebral aneurysm 
has been reported. 
The recurrence risk of CoA increases in the offspring of parents with 
CoA and with the number of affected relatives. The reported recurrence 
risk of CoA is about 2% if one sibling is affected and approximately 6% 
if two siblings are affected.(62) Fetal echocardiography is mandatory 
early in pregnancy.
LATE MANAGEMENT RECOMMENDATIONS FOR 
THE ADULT WITH COARCTATION
CoA is a life-long disease and careful follow-up with serial assessment 
is required through infancy and adulthood to help prevent complications 
and to monitor for recurrences.(63) Follow-up studies include a search 
for late complications, e.g. arterial hypertension, recurrent obstruction, 
aneurysm formation or other associated anomalies. Clinical examination 
alone is not suffi cient and the use of modern imaging techniques is 
essential. 
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